In vitro activities of newer quinolones against bacteroides group organisms. - Wikidata - awgldk - TriplyDB

In vitro activities of newer quinolones against bacteroides group organisms.

In vitro activities of newer quinolones against bacteroides group organisms.

http://www.wikidata.org/entity/Q34143059

about

Bacteroides: the good, the bad, and the nitty-gritty In vitro activity of moxifloxacin against 923 anaerobes isolated from human intra-abdominal infections.In vitro antianaerobic activity of DX-619, a new des-fluoro(6) quinolone Moxifloxacin in the treatment of skin and skin structure infections.In vitro activities of tigecycline against the Bacteroides fragilis group.Levofloxacin for the treatment of community-acquired pneumonia.In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.Efficacy of moxifloxacin monotherapy versusgatifloxacin monotherapy, piperacillin-tazobactam combination therapy, and lindamycin plus gentamicin combination therapy: An experimental study in a rat model of intra-abdominal sepsis induced by fluoroqui In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections.Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.

P2860

Q24685642-57A5BA0D-3F96-4C80-ABB3-E52467D4DE1E Q34301520-448BDFB8-1AF4-4DCC-B3C1-C8749CA78590 Q35127828-F3F5317B-CC2E-4747-A055-5DE53511ABD8 Q35919259-9AFF007F-9002-473A-89DC-12240B6AA49B Q36490533-8D0C2D41-907B-4645-B6B5-C366CF56E546 Q36670872-4F219B3C-74AB-403D-9A60-BC398F8BA44D Q36993524-CC4E1F81-62F2-49B5-8F10-BF938D0DCD50 Q37661065-67AC8B5E-77EE-41C4-97A2-1D6EC0E7EB0E Q40622123-6850B33D-6ED7-4093-8C5F-3C191D783C53 Q41005606-D63625B9-0A44-4114-8D55-5572A979852E Q45074770-5E5985D4-0B0C-4255-91E6-2F02D6CCD595

P2860

In vitro activities of newer quinolones against bacteroides group organisms.

http://www.wikidata.org/entity/Q34143059

description

2002 nî lūn-bûn

@nan

2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

In vitro activities of newer quinolones against bacteroides group organisms.

@ast

In vitro activities of newer quinolones against bacteroides group organisms.

@en

In vitro activities of newer quinolones against bacteroides group organisms.

@nl

type

label

In vitro activities of newer quinolones against bacteroides group organisms.

@ast

In vitro activities of newer quinolones against bacteroides group organisms.

@en

In vitro activities of newer quinolones against bacteroides group organisms.

@nl

prefLabel

In vitro activities of newer quinolones against bacteroides group organisms.

@ast

In vitro activities of newer quinolones against bacteroides group organisms.

@en

In vitro activities of newer quinolones against bacteroides group organisms.

@nl

P1433

Q34143059-7E4FDFA6-0417-4326-B134-8E09B33F341C

P1476

Q34143059-0A4E5584-C073-44B4-915B-34F751093E3A

P2093

Q34143059-0E8BAA4F-7E83-470D-A3BB-7948BC6F1424

Q34143059-23EFFF28-9235-4308-86FE-970BCF0733EE

Q34143059-2A9E0F2D-FE5E-4D0F-9C0F-6CF14DF528F6

Q34143059-3AF47EA0-04C0-46A7-B416-226E5069C8BC

Q34143059-438DE985-D7AF-457B-9837-2C9E7887F974

Q34143059-4D27E263-CCE5-4C75-814A-8199981B33B3

Q34143059-60C0FAE4-E719-4CA0-BCBD-DB218BF9CF41

Q34143059-7FF4B329-74EE-425F-A3F9-11E8A1715336

Q34143059-83F4ABA2-33D5-44D2-92E1-024687029753

Q34143059-A9B3989B-A192-4373-B9FE-3DDFCD9E4D73

P2860

Q34143059-0112000B-4FF9-41CB-A487-D7B2F0C6D2D1

Q34143059-491C1C0D-9926-4DD8-914E-5C3C9E8ED73D

Q34143059-686F32BB-FE3B-4C82-A33F-CCAD881340FA

Q34143059-6BC5492E-5339-4774-817E-62F7472D369D

Q34143059-80738A8E-4DFD-488E-B418-61BF9FA23B7F

Q34143059-82A10C89-D696-4D00-AE54-7FF4317177AD

Q34143059-B2564631-6266-4148-B898-09F639FFE6CE

Q34143059-BB5EE5EB-4B3F-4C44-97DD-6706D388D771

Q34143059-D68E7A2A-7911-4FF3-9B63-E1EC64F056F1

Q34143059-DBCB27BE-A350-4829-BFF9-48183C99A9CB

P304

Q34143059-3E55F2DA-BD58-4782-8C9E-3B3E39E2609D

P31

Q34143059-D021DBFC-D22B-465E-9EF9-CC8383CABA88

P356

Q34143059-C3473975-5D94-45EB-8610-81537F21B1D7

P407

Q34143059-AAC85015-5B30-4E20-923B-DD306893511B

P433

Q34143059-D50A8A80-7240-4249-A6D4-58B9A21C7AA4

P478

Q34143059-AB9044A7-B892-4BF7-8B8F-6C8D74C1EA8A

P577

Q34143059-4066EAB1-4951-445C-BDFD-D6E7AD4124A1

P698

Q34143059-8972AB9A-956F-4691-8AC0-629D7784B09D

P921

Q34143059-158A35FE-D3B3-4B56-AE2D-8A117116D985

P932

Q34143059-4E4D3370-090F-4A66-93CA-BB427587F813

P356

AAC.46.10.3276-3279.2002

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro activities of newer quinolones against bacteroides group organisms.

@en

P2093

C Pierson

http://www.w3.org/2001/XMLSchema#string

D R Snydman

http://www.w3.org/2001/XMLSchema#string

D W Hecht

http://www.w3.org/2001/XMLSchema#string

E Goldstein

http://www.w3.org/2001/XMLSchema#string

J Rihs

http://www.w3.org/2001/XMLSchema#string

L A McDermott

http://www.w3.org/2001/XMLSchema#string

L Harrell

http://www.w3.org/2001/XMLSchema#string

N V Jacobus

http://www.w3.org/2001/XMLSchema#string

R Ruthazer

http://www.w3.org/2001/XMLSchema#string

R Venezia

http://www.w3.org/2001/XMLSchema#string

P2860

Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756

In vitro activity of BAY 12-8039, a new fluoroquinolone

Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms.

Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996

Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents.

Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U

Comparative activities of eight quinolones against members of the Bacteroides fragilis group.

Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria

Comparative in vitro activities of clinafloxacin and trovafloxacin against 1,000 isolates of bacteroides fragilis group: effect of the medium on test results.

Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species

P304

3276-3279

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.46.10.3276-3279.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12234859

http://www.w3.org/2001/XMLSchema#string

P921

P932

128763

http://www.w3.org/2001/XMLSchema#string